Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: St Louis MO, Chicago IL, Zion IL, Cincinnati OH,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: St Louis MO, Osage Beach MO, Memphis TN, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: St Louis MO, Bettendorf IA, Iowa City IA, Westwood KS,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06881784
Phase3, Recruiting
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: St Louis MO, Saint Paul MN, Atlanta GA, Durham NC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03606967
Phase2, Recruiting
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: St Louis MO, Creve Coeur MO, Shiloh IL, Alton IL,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500481
Phase3, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: St Louis MO, Denver CO, Oklahoma City OK,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: St Louis MO, Edgewood KY, Cleveland OH, Pittsburgh PA,
Sponsor: NextCure, Inc.
Sex: All
Age: 18+
Code: NCT06774963
Phase1, Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: St Louis MO, Columbia MO, Indianapolis IN,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase2, Recruiting
Study of XB010 in Subjects With Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors,
Location: St Louis MO, Nashville TN, Chicago IL, Oklahoma City OK,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06545331
Phase1, Recruiting
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: St Louis MO, Creve Coeur MO, Chesterfield MO, Shiloh IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT04803201
Phase2, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: St Louis MO, Florissant MO, Shiloh IL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase3, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: St Louis MO, Nashville TN, Fairfax VA, Austin TX,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase1, Recruiting
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
for
Small Cell Lung Cancer, Renal Cell Carcinoma (RCC),
Location: St Louis MO, Birmingham AL, Cleveland OH
Sponsor: Advenchen Pharmaceuticals, LLC.
Sex: All
Age: 18+
Code: NCT05363280
Phase2, Recruiting
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
for
Solid Tumours
Location: St Louis MO, Houston TX, Fairfax VA, Philadelphia PA,
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT06725758
Phase1, Phase2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Location: St Louis MO, Florissant MO, Creve Coeur MO, Shiloh IL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase1, Phase2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: St Louis MO, Springfield MO, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase3, Recruiting
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: St Louis MO, Rochester MN, Jacksonville FL,